Vermont Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 8 (73% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 1,768
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 3.71%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 87
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 1.18%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 85.24% 96.55%
White, Hispanic/Latino Patients 0.96% 0.00%
Black/African American, Non-Hispanic/Latino Patients 0.85% 0.00%
Black/African American, Hispanic/Latino Patients 0.00% 0.00%
Asian Patients3 0.45% 1.15%
American Indian/Alaska Native Patients3 0.57% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.06% 0.00%
Patients with More than one race3 0.00% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.40% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.87% 0.00%
Unreported/Refused to Report Race and Ethnicity 9.62% 2.30%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 303
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 9.57%
COVID-19 Immunization Series Completed 355
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 9.77%
COVID-19 Immunization Series Additional 1,775
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 3.98%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 68.65% 67.61% 76.11%
White, Hispanic/Latino Patients 1.32% 1.41% 0.23%
Black/African American, Non-Hispanic/Latino Patients 3.63% 3.10% 0.62%
Black/African American, Hispanic/Latino Patients 0.00% 0.00% 0.00%
Asian Patients3 1.32% 1.41% 1.35%
American Indian/Alaska Native Patients3 0.33% 1.13% 0.23%
Native Hawaiian/Other Pacific Islander Patients3 0.33% 0.28% 0.00%
Patients with More than one race3 0.00% 0.00% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.33% 0.00% 0.73%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.98% 1.69% 1.13%
Unreported/Refused to Report Race and Ethnicity 22.11% 23.38% 19.61%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 0.00%
1 to 24 Hours 12.50%
More Than 24 Hours 87.50%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 75.00%
Vaccine confidence 0.00%
Vaccine storage capacity 12.50%
Vaccine supply 12.50%
Other 12.50%
None 0.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 25.00%
Average Percent of Health Center Visits Conducted Virtually 15.00%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 25.00%
Number of Mobile Van Sites 6
Number of Pop-up Clinics 2
Number of School-Based Vaccination Sites 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 50.00%
None 50.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 12.50%
Therapy administration/onsite logistics 37.50%
Other 12.50%
None 50.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021